Invention Grant
- Patent Title: Immunoassay for detecting tumor pyruvate kinase M2
-
Application No.: US16935833Application Date: 2020-07-22
-
Publication No.: US11255856B2Publication Date: 2022-02-22
- Inventor: Mahboubeh Razzaqi
- Applicant: Mahboubeh Razzaqi
- Applicant Address: IR Qom
- Assignee: Mahboubeh Razzaqi
- Current Assignee: Mahboubeh Razzaqi
- Current Assignee Address: IR Qom
- Agency: Bajwa IP Law Firm
- Agent Haris Zaheer Bajwa
- Main IPC: G01N33/573
- IPC: G01N33/573 ; G01N33/577 ; C07K16/40 ; G01N33/558

Abstract:
An immunoassay kit including a monoclonal antibody coupled to a labeling agent (labeled mAb) for detecting tumor pyruvate kinase M2 (tM2-PK) in a biological sample. The monoclonal antibody includes a heavy chain variable region (HCVR) including heavy chain complementarity-determining regions (CDRs) (SEQ ID NOs: 3, 4, and 5) and a light chain variable region (LCVR) including light CDRs (SEQ ID NOs: 7, 8, and 9).
Public/Granted literature
- US20210140966A1 IMMUNOASSAY FOR DETECTING TUMOR PYRUVATE KINASE M2 Public/Granted day:2021-05-13
Information query
IPC分类: